NEWLY DIAGNOSED MYC/BCL2 DOUBLE-EXPRESSOR DLBCL

Clinical trials for NEWLY DIAGNOSED MYC/BCL2 DOUBLE-EXPRESSOR DLBCL explained in plain language.

Never miss a new study

Get alerted when new NEWLY DIAGNOSED MYC/BCL2 DOUBLE-EXPRESSOR DLBCL trials appear

Sign up with your email to follow new studies for NEWLY DIAGNOSED MYC/BCL2 DOUBLE-EXPRESSOR DLBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Chemo-Free start shows promise for High-Risk lymphoma in older adults

Disease control Ongoing

This study tests a three-step treatment for elderly patients (ages 60-80) with a high-risk type of lymphoma called double-expressor DLBCL. First, patients receive a chemotherapy-free drug combination. Depending on how well the cancer responds, they then get standard chemotherapy …

Matched conditions: NEWLY DIAGNOSED MYC/BCL2 DOUBLE-EXPRESSOR DLBCL

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 11, 2026 12:12 UTC

NEWLY DIAGNOSED MYC/BCL2 DOUBLE-EXPRESSOR DLBCL

Get alerted when new NEWLY DIAGNOSED MYC/BCL2 DOUBLE-EXPRESSOR DLBCL trials appear

Chemo-Free start shows promise for High-Risk lymphoma in older adults